-
-
Call more information
660-596-2224 -
Author: Francesca Mathewes Becker’s ASC Review Amid mounting reimbursement pressures and rising operational costs, ASC leaders are looking to models for managing anesthesia costs and staffing that will sustain them into the future. Peter Bravos, MD, chief medical officer of Sacramento, Calif.-based Sutter Health’s surgery center division, recently joined Becker’s to discuss the ways that ASCs can […]
Read MoreAuthor: Abramovich I et al. Current Opinion in Anesthesiology 38(5):547–552, October 2025. doi:10.1097/ACO.0000000000001524 This review examines remimazolam—an ultrashort-acting benzodiazepine—in neuroanesthesia. Across recent RCTs and case reports, remimazolam generally produced fewer hypotensive episodes, reduced vasopressor requirements, and allowed faster emergence, especially when flumazenil was used. However, higher BIS values at comparable sedation levels raise monitoring accuracy […]
Read MoreAuthor: Goh G et al. Anaesthesia Critical Care & Pain Medicine, 2025. doi:10.1016/j.accpm.2025.101591 This multicenter retrospective cohort from 12 Queensland ICUs (2015–2021) evaluated ICU-acquired metabolic alkalosis. Among 24,676 eligible adult admissions (ICU LOS >48 h; no alkalosis in first 24 h), 36% (n=8,889) developed alkalosis, typically on day 4 (IQR 3–6). Diuretics (28%) and steroids […]
Read MoreAuthor: Francesca Mathewes Becker’s ASC Review Private equity’s presence in anesthesia has been the subject of several recent lawsuits and studies on healthcare costs as the specialty becomes increasingly consolidated. Here are eight notes private equity group’s recent moves in anesthesia: 1. A study published in July by the University of Chicago’s Booth School of Business found that anesthesia costs […]
Read MoreAuthor: Adelmann D et al. Anesthesiology, September 18, 2025. doi:10.1097/ALN.0000000000005759 This multicenter observational study evaluated the TEG® 6s Global Hemostasis – Heparin Neutralization cartridge, newly cleared by the FDA, in patients undergoing cardiovascular surgery with cardiopulmonary bypass (CPB) or other invasive cardiac procedures requiring unfractionated heparin. A total of 543 blood samples from 185 patients […]
Read MoreHardin Medical Center (122 beds) is offering a rare CRNA-only practice with full autonomy and an unbeatable lifestyle. • Schedule: 2 weeks on / 1 week off (17 weeks off annually)• Model: Independent CRNA practice – no anesthesiologist supervision• Case Mix: General surgery, ortho, endo, OB/GYN (epidurals & C-sections)• No Complex Cases: No hearts, no […]
Read MoreIf you’re an anesthesiologist searching for a balanced lifestyle and rewarding work, you’ll want to check out this opportunity. Our all-anesthesiologist group is seeking a dedicated team member to join our collaborative practice. Position Highlights: Zero Call for 3 Weeks: Enjoy three weeks of no call duty, followed by one week of call. Even during […]
Read MoreAutor: Francesca Mathewes Becker’s ASC Review As the anesthesia staffing crisis persists across healthcare settings, ASC and perioperative leaders are putting more emphasis on investing in members of the anesthesia care team to maintain a high standard of care quality and keep facilities running smoothly. Aaron Kalin, DO, medical director and chair of anesthesiology at […]
Read MoreAuthor: Yasgur Batya Swift Medscape Medical News SummaryNearly one in four U.S. adults reported living with chronic pain in 2023, up from 20% in 2020, with 8.5% experiencing pain severe enough to limit daily activities. Chronic pain costs the healthcare system over $725 billion annually and is the leading cause of disability worldwide. Experts note […]
Read MoreAuthor: Megan Brooks Medscape Medical News Interest in kratom has surged in the United States, with estimates of up to 16 million users and $2 billion in annual sales. While some believe kratom may ease opioid withdrawal, experts caution that products containing its potent metabolite, 7-hydroxymitragynine (7-OH), may themselves be addictive and harmful. Kratom is […]
Read More